Clavulanate Potassium Oral Suspension Western Medicine Suspension Augmentin
|FOB Price:||US $0.3 / Piece|
|Min. Order:||20,000 Pieces|
|Min. Order||FOB Price|
|20,000 Pieces||US $0.3/ Piece|
|Production Capacity:||500000 Bottle Per Month|
|Payment Terms:||L/C, T/T|
- Model NO.: 156.25MG/5ML 60ML
- Usage Mode: For oral administration
- State: Solid
- Pharmaceutical Technology: Chemical Synthesis
- Transport Package: Color Box
- Origin: China
- Application: Internal Medicine
- Suitable for: Adult
- Type: Biological Products
- Trademark: As per customer
- Specification: 156.25MG/5ML 60ML
Western Medicin Augmentin ( Co-amoxiclav) Suspension Oral amoxicillin clavulanate potassium B.P.
as Amoxycillin trihydrate(BP) and Clavulanic acid as potassium salt (BP).
AUGMENTIN is an antibiotic agent with notably broad spectrum of activity against the commonly occurring.
Bacterial pathogens in general practice and hospital. The β-lactamase inhibitory action of clavulanate extends the spectrum of amoxycillin to embrace a wider range of organisms , including many resistant to other β-lactam antibiotics.
AUGMENTIN should be used in accordance with local official antibiotic-prescribing guldelines and local susceptibility data.
AUGMENTIN oral presentations for three times daily dosing , are indicated for shor-term treatment of bacterial infections at the following sites:
Upper respiratory tract infections (including ENT) e.g. tonsillitis , sinusitis , otitis media.
Lower respiratory tract infections e.g. acute exacerbation of chronic bronchitis , lobar and bronchopneumonia.
Genito-urinary tract infections e.g. cystitis , urethritis , pyelonephritis.
Skin and soft tissue infections , e.g. boils, abscesses, cellulitis , wound infections.
Bone and joint infections e.g. osteomyelitis.
Dental infections e.g. dentoalveolar abscess
Other infections e.g. intra-abdominal sepsis.
Susceptibility to AUGMENTIN will vary with geography and time . Local susceptibility data should be consulted where available , and microbiological sampling and susceptibility testing performed where necessary.
Infections caused by amoxycillin susceptible organisms are amenable to AUGMENTIN treatment due to its amoxycillin content. Mixed infections caused by amoxycillin susceptible organisms in conjunction with AUGMENTIN susceptible β-lactamase producing organisms may therefore be treated with AUGMENTIN.
Dosage and Administration
Usual dosages for the treatment of infection
Adults and children over 12 years.
Mild-Moderate One AUGMENTIN
infection 375mg tablet three times a day.
Or one AUGMENTIN 625 mg tablet twice daily
Severe One AUGMENTIN 1g
infection tablet twic daily
One AUGMENTIN 625mg tablet three times a day. Where the 625 mg tablet is not available, a dose of two AUGMENTIN 375 mg tablets three times a day may be taken.
Therapy can be started parenterally and continued with an oral preparation.
The usual recommended daily dosage is 25mg/kg/day in divided doses every eight hours. The tablet below presents guidance for children.
Under 1 year 25mg/kg/day, for example a 7.5kg child would require 2mal AUGMENTIN 156.25mg suspension 3 times a day.
1-6 years 5ml AUGMENTIN
(10-18kg) 156.25mg suspension 3 times a day.
Over 6 years 5ml AUGMENTIN
(18-40kg) 312.5mg suspension 3 times a day.
In more serious infections the dosage may be increased up to 50mg/kg/day in divided doses every eight hours.
Each 25mg AUGMENTIN provides 20mg amoxycillin and 5mg clavulanate.
AUGMENTIN 375mg and 625mg tablets are not recommended in children of 12 years and under.
Dosage in dental infections (e.g. dentoalveolar abscess)
Adults and children over 12 years: One AUGMENTIN 375 mg tablet 3 times a day for five days.
Dosage in renal impairment
(Creatinine clearance >30ml/min)
(Creatinine clearance 10-30ml/min)
|Severe impairment(Creatinine clearance <10ml/min)|
(i.e. either one 375 mg tablet
Three time a day, one 625mg tablet twice daily or one 1g tablet twice daily)
One 375 mg tablet or one 625mg tablet 12 hourly.
The 1g tablet should not be administered.
Not more than one 375mg tablet 12 hourly;
625mg tablets are not recommended.
(Creatinine clearance>30 ml/min)
|Moderate impairment(Creatinine clearance 10-30mgl/min)||Severe impairment(Creatinine clearance<10ml/min)|
|No change in dosage|
18.75mg/kg given twice daily
(maximum 625mg twice daily)
18.75mg/kg given as a single